In today’s briefing:
- Global Health Pre-IPO – RHP Updates – Post-COVID Growth Likely to Normalize
- Yunsung F&C Valuation Analysis
Global Health Pre-IPO – RHP Updates – Post-COVID Growth Likely to Normalize
- Global Health (Medanta) (GH IN) is looking to raise approximately US$270m in its upcoming India IPO.
- Global Health (GH) is a hospital network that operates under the Medanta brand. The firm currently has five hospitals in operation and one more planned for development.
- We had looked at the company’s past performance in our previous note. In this note, we’ll talk about its RHP updates.
Yunsung F&C Valuation Analysis
- Our base case valuation of Yunsung F&C is target price of 53,360 won per share, which is 0.7% higher than the low end of the IPO price range.
- Given the lack of upside, we would avoid this IPO.
- Yunsung F&C is one of the leaders in Korea in producing mixers for rechargeable battery materials for customers including LG Energy Solution and SK On.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
